ConductScience.org, home

Paper22956830

Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.

Cortes CJ and 4 others. J Neurosci, 2012. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease. Papers, record 22956830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22956830

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rapamycin delays disease onset and prevents PrP plaque deposition in a mouse model of Gerstmann-Sträussler-Scheinker disease.
PubMed
Journal
J Neurosci
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.29
iCite
Revised in PubMed
2021-10-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cortes CJConstanza J
2Qin KKefeng
3Cook JJulie
4Solanki AAni
5Mastrianni JAJames A

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Disease Models, AnimalMajor topic
Gerstmann-Straussler-Scheinker DiseaseMajor topic
Plaque, AmyloidMajor topic
PrionsMajor topic
SirolimusMajor topic
Animals
Female
Male
Mice
Mice, Knockout
Mice, Transgenic
Random Allocation
Time Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 NS051480NINDS NIH HHSUnited StatesR01NS051480PubMed and NIH
R01NS051480NINDS NIH HHSUnited StatesR01NS051480PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117330103The anticancer drug imatinib induces cellular autophagy.Leukemia2007https://conductscience.org/library/papers/17330103PubMed
218199701Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.Mol Pharmacol2008https://conductscience.org/library/papers/18199701PubMed
311522774Prion protein protects human neurons against Bax-mediated apoptosis.J Biol Chem2001https://conductscience.org/library/papers/11522774PubMed
417118264Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.Curr Top Dev Biol2006https://conductscience.org/library/papers/17118264PubMed
512917444Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.J Biol Chem2003https://conductscience.org/library/papers/12917444PubMed
69811807Prions.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9811807PubMed
716226444Growing roles for the mTOR pathway.Curr Opin Cell Biol2005https://conductscience.org/library/papers/16226444PubMed
819767652Autophagy, prion infection and their mutual interactions.Curr Issues Mol Biol2010https://conductscience.org/library/papers/19767652PubMed
916368705Rapamycin alleviates toxicity of different aggregate-prone proteins.Hum Mol Genet2006https://conductscience.org/library/papers/16368705PubMed
1012878853Rapamycins: mechanism of action and cellular resistance.Cancer Biol Ther2003https://conductscience.org/library/papers/12878853PubMed
1111978769Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy.Hum Mol Genet2002https://conductscience.org/library/papers/11978769PubMed
1217182613Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein.J Biol Chem2007https://conductscience.org/library/papers/17182613PubMed
1318250315Lithium delays progression of amyotrophic lateral sclerosis.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18250315PubMed
1417331981Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).Hum Mol Genet2007https://conductscience.org/library/papers/17331981PubMed
1517849316The tyrosine kinase inhibitor imatinib mesylate delays prion neuroinvasion by inhibiting prion propagation in the periphery.J Neurovirol2007https://conductscience.org/library/papers/17849316PubMed
1611052993Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response.Am J Physiol Gastrointest Liver Physiol2000https://conductscience.org/library/papers/11052993PubMed
1719675240A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.J Neurosci2009https://conductscience.org/library/papers/19675240PubMed
1820376313Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.PLoS One2010https://conductscience.org/library/papers/20376313PubMed
1920190788Protein aggregation diseases: pathogenicity and therapeutic perspectives.Nat Rev Drug Discov2010https://conductscience.org/library/papers/20190788PubMed
2020174468Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.PLoS One2010https://conductscience.org/library/papers/20174468PubMed

See all 47 referencesDownload CSV of references

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
42008486Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex.PLoS Pathog2026https://conductscience.org/library/papers/42008486PubMed
41004055Therapeutic Trajectories in Human Prion Diseases.Subcell Biochem2025https://conductscience.org/library/papers/41004055PubMed
41004053New Therapeutic Modalities in Prion Diseases.Subcell Biochem2025https://conductscience.org/library/papers/41004053PubMed
40956390Retinitis Pigmentosa-Associated Gene TRIM49 Regulates ULK1-Mediated Autophagy and Photoreceptor Phagocytosis by the Retinal Pigment Epithelium.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40956390PubMed
40781739Contrasting roles of autophagy in cellular prion infection.Autophagy2025https://conductscience.org/library/papers/40781739PubMed
40708570Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).Explor Drug Sci2025https://conductscience.org/library/papers/40708570PubMed
40532025Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss.PLoS Pathog2025https://conductscience.org/library/papers/40532025PubMed
40342093Autophagy in cancer and protein conformational disorders.FEBS Lett2025https://conductscience.org/library/papers/40342093PubMed
38557815Anti-prion drugs do not improve survival in novel knock-in models of inherited prion disease.PLoS Pathog2024https://conductscience.org/library/papers/38557815PubMed
37142830Targeting the biology of aging with mTOR inhibitors.Nat Aging2023https://conductscience.org/library/papers/37142830PubMed
36984858Neurodegeneration, Mitochondria, and Antibiotics.Metabolites2023https://conductscience.org/library/papers/36984858PubMed
36558997FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36558997PubMed
36148145Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.Front Neurosci2022https://conductscience.org/library/papers/36148145PubMed
35676449Brain aging is faithfully modelled in organotypic brain slices and accelerated by prions.Commun Biol2022https://conductscience.org/library/papers/35676449PubMed
34461258SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.Biochim Biophys Acta Mol Basis Dis2021https://conductscience.org/library/papers/34461258PubMed
34209482MicroRNAs in Prion Diseases-From Molecular Mechanisms to Insights in Translational Medicine.Cells2021https://conductscience.org/library/papers/34209482PubMed
33117143Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease.Front Aging Neurosci2020https://conductscience.org/library/papers/33117143PubMed
33092231A New Take on Prion Protein Dynamics in Cellular Trafficking.Int J Mol Sci2020https://conductscience.org/library/papers/33092231PubMed
32984276An Update on Autophagy in Prion Diseases.Front Bioeng Biotechnol2020https://conductscience.org/library/papers/32984276PubMed
32937909Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease.Int J Mol Sci2020https://conductscience.org/library/papers/32937909PubMed

See all 61 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22956830

GET https://conductscience.org/api/papers/v1/22956830/references?page=2